Alton Group: The Irvine biomedical instrument and...
- Share via
Alton Group: The Irvine biomedical instrument and computer products manufacturer posted a loss of $125,000, or 4 cents a share, for its first fiscal quarter, which ended Sept. 30. That contrasted with a profit of $1,000, or 8 cents a share, for the corresponding period last year. Quarterly sales increased 35% to $300,000 from $222,000.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
